BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing

  August 4, 2025

   · 

  1 min read
• Press Releases

  AB Science announces the successful completion of a 2.55 million euros private placement

  August 4, 2025

   · 

  11 min read
• Press Releases

  Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

  August 4, 2025

   · 

  2 min read
• Press Releases

  Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - August 1, 2025

  August 4, 2025

   · 

  1 min read
• Press Releases

  Pharming Group to participate in August 2025 investor conference

  August 4, 2025

   · 

  1 min read
• Press Releases

  Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results

  August 4, 2025

   · 

  25 min read
• Press Releases

  BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter

  August 4, 2025

   · 

  6 min read
• Press Releases

  Medicus Pharma Ltd. Announces a Memorandum of Understanding (MOU) with Helix Nanotechnologies Inc. to Develop Thermostable Infectious Disease Vaccines

  The MOU intends to combine proprietary mRNA vaccine platform of HelixNano with proprietary Microneedle array (MNA) delivery platform of Medicus.

  August 4, 2025

   · 

  8 min read
• Press Releases

  BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time

  August 4, 2025

   · 

  2 min read
• Press Releases

  Marea Therapeutics Enrolls First Patient in Phase 2b TYDAL-TIMI 78 Clinical Study Evaluating MAR001 in Adults at Risk of ASCVD

  August 4, 2025

   · 

  3 min read